Spokane clinic offering trials for Parkinson’s disease

A biomedical research group in Spokane is offering clinical trials to patients who are suffering from neurological conditions like Parkinson’s disease.

Each year, 60,000 Americans are diagnosed with Parkinson’s and our community is no exception. That’s why doctors with Inland Northwest Research are trying to spread the word.

“It sneaks up on you and continues to take away bites of you,” said James Hedtke, living with Parkinson’s disease.

Hedtke currently lives in Portland, but decided to make his way to Spokane when he heard about the clinical trials being offered at Inland Northwest Research.

“That’s when I met Dr. Aldred,” said Hedtke.

“Not only do they have access to top line cutting edge neurological subspecialty care, but they also have access to participate in truly globally significant clinical trials,” said Dr. Jason Aldred with Inland Northwest Research Group.

The research group focuses on providing clinical trials for patients diagnosed with neurological disorders.

“Working on developing new treatments that can significantly change Parkinson’s progression or significantly slow it down,” said Aldred.

The trial requires patients to follow-up once a month, as well as stay off of any prescription medications.

“On the day of the infusion, I get an IV treatment that lasts an hour. I’m here about four hours or so,” said Hedtke.

While each day may be a struggle for Hedtke, he’s aware of the significance this clinical trial may have not only on himself, but also for others living with the disease.

“It’s going to contribute to the science that allows us to understand and maybe lead to a treatment,” Hedtke said.

If you’re interested in learning more about the clinical trials offered at Inland Northwest Research, you can visit their website.